News

Discover the news of an experienced Contract Research Organization specialized in Biostatistics and eClinical services to optimize your clinical trials.

Assessing Treatment Benefit in Immuno-oncology

News & Events

Adaptations to tumor response and progression criteria for immune therapies. Abstract Immuno-oncology is a buoyant field of research, with recently developed drugs showing unprecedented response rates and/or a hope for a meaningful prolongation of the overall survival of some patients. […]

Read more

Statistical Aspects in Adjuvant and Neoadjuvant Trials for Gastrointestinal Cancer in 2020: Focus on Time-To-Event Endpoints

News & Events

Testing novel agents in gastrointestinal cancer requires continued attention to statistical issues related to endpoints. Purpose of Review: Clinical-trial design, analysis, and interpretation entails the use of efficient and reliable endpoints. Statistical issues related to endpoints warrant continued attention, as […]

Read more

IDDI at DIA Global Annual Meeting

June 14, 2020 — June 18, 2020

News & Events

The DIA 2020 Global Annual Meeting will still go on, in the digital realm! IDDI will have a virtual booth – Come and e-meet us! Are you looking for solutions to optimize clinical processes for your  trials? Meet our experts at DIA 2020 […]

Read more

IDDI at Clinical Operations online strategy meeting

June 25, 2020

News & Events

IDDI Partner at the Clinical Operations online strategy meeting Join IDDI at Proventa Clinical Operations online strategy meeting where clinical and pharmacovigilance leaders can share insight and explore new partnerships. Join our global community of pharma, biotech and investors all […]

Read more

IDDI at the Online Oncology Strategy Meeting

June 30, 2020

News & Events

IDDI Partner at the Proventa Online Oncology Strategy Meeting Join IDDI and pharma, biotech and investors from across Europe at the Online Oncology Strategy Meeting. Explore partnerships, challenges and innovations with leaders from across the sector, and contribute to discussions. […]

Read more